Long-term physiological T3 supplementation in hypertensive heart disease in rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 309, Issue 6, 2015, Pages H1059-H1065

  Weltman, Nathan Y ^a   Pol, Christine J ^b   Zhang, Youhua ^b   Wang, Yibo ^b   Koder, Adrienne ^b   Raza, Sarah ^b   Zucchi, Riccardo ^c   Saba, Alessandro ^c   Colligiani, Daria ^c   Gerdes, A Martin ^b  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Fibrosis; Heart failure; Hypertension; Left ventricle; Thyroid hormone

Indexed keywords

COLLAGEN; LIOTHYRONINE; THYROXINE; MYOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FREE THYROXINE INDEX; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HYPERTENSION; LIOTHYRONINE BLOOD LEVEL; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; THYROXINE BLOOD LEVEL; WALL STRESS; WESTERN BLOTTING; WISTAR KYOTO RAT; ANIMAL; COMPLICATION; DRUG EFFECTS; HEART; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; HYPOTHYROIDISM; METABOLISM; RANDOMIZATION; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; COLLAGEN; FEMALE; HEART; HEART FAILURE; HEART VENTRICLES; HYPERTENSION; HYPOTHYROIDISM; MYOSINS; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; THYROXINE; TRIIODOTHYRONINE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84941696068     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00431.2015     Document Type: Article

References (23)

1. Anonymous. The coronary drug project. Design, methods, and baseline results. Circulation 47, Suppl 3: I1–I50, 1973
2. Chen YF, Weltman NY, Li X, Youmans S, Krause D, Gerdes AM. Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats. J Transl Med 11: 40, 2013
3. Gerdes AM. Restoration of thyroid hormone balance: a game changer in the treatment of heart failure? Am J Physiol Heart Circ Physiol 308: H1–H10, 2015
4. Gerdes AM, Iervasi G. Thyroid replacement therapy and heart failure. Circulation 122: 385–393, 2010
5. Goldman S, McCarren M, Morkin E, Ladenson PW, Edson R, Warren S, Ohm J, Thai H, Churby L, Barnhill J, O’Brien T, Anand I, Warner A, Hattler B, Dunlap M, Erikson J, Shih MC, Lavori P. DITPA (3,5-diiodothyropropionic acid), a thyroid hormone analog to treat heart failure: phase II trial Veterans Affairs cooperative study. Circulation 119: 3093–3100, 2009
6. Kisso B, Patel A, Redetzke R, Gerdes AM. Effect of low thyroid function on cardiac structure and function in spontaneously hypertensive heart failure rats. J Card Fail 14: 167–171, 2008
7. Kuzman JA, Tang Y, Vogelsang KA, Said S, Anderson BE, Morkin E, Gerdes AM. Thyroid hormone analog, diiodothyropropionic acid (DITPA), exerts beneficial effects on chamber and cellular remodeling in cardiomyopathic hamsters. Can J Physiol Pharmacol 85: 311–318, 2007
8. Olivares EL, Marassi MP, Fortunato RS, da Silva AC, Costa-e-Sousa RH, Araujo IG, Mattos EC, Masuda MO, Mulcahey MA, Huang SA, Bianco AC, Carvalho DP. Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study. Endocrinology 148: 4786–4792, 2007
9. Onodera T, Tamura T, Said S, McCune SA, Gerdes AM. Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension. Hypertension 32: 753–757, 1998
10. Pingitore A, Iervasi G, Gerdes MA. Letter by Pingitore et al. regarding article, “DITPA (3,5-diiodothyropropionic acid), a thyroid hormone analog to treat heart failure: phase II trial Veterans Affairs cooperative study”. Circulation 121: e240; author reply e241, 2010
11. Pol CJ, Muller A, Zuidwijk MJ, van Deel ED, Kaptein E, Saba A, Marchini M, Zucchi R, Visser TJ, Paulus WJ, Duncker DJ, Simonides WS. Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. Endocrinology 152: 669–679, 2011
12. Saba A, Chiellini G, Frascarelli S, Marchini M, Ghelardoni S, Raffaelli A, Tonacchera M, Vitti P, Scanlan TS, Zucchi R. Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 151: 5063–5073, 2010
13. Simonides WS, Mulcahey MA, Redout EM, Muller A, Zuidwijk MJ, Visser TJ, Wassen FW, Crescenzi A, da-Silva WS, Harney J, Engel FB, Obregon MJ, Larsen PR, Bianco AC, Huang SA. Hypoxiainducible factor induces local thyroid hormone inactivation during hypoxic- ischemic disease in rats. J Clin Invest 118: 975–983, 2008
14. Tamura T, Onodera T, Said S, Gerdes AM. Correlation of myocyte lengthening to chamber dilation in the spontaneously hypertensive heart failure (SHHF) rat. J Mol Cell Cardiol 30: 2175–2181, 1998
15. Tamura T, Said S, Gerdes AM. Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension 33: 676–680, 1999
16. Tang YD, Kuzman JA, Said S, Anderson BE, Wang X, Gerdes AM. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation 112: 3122–3130, 2005
17. Thomas TA, Kuzman JA, Anderson BE, Andersen SM, Schlenker EH, Holder MS, Gerdes AM. Thyroid hormones induce unique and potentially beneficial changes in cardiac myocyte shape in hypertensive rats near heart failure. Am J Physiol Heart Circ Physiol 288: H2118–H2122, 2005
18. Wassen FW, Schiel AE, Kuiper GG, Kaptein E, Bakker O, Visser TJ, Simonides WS. Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. Endocrinology 143: 2812–2815, 2002
19. Weltman NY, Ojamaa K, Savinova OV, Chen YF, Schlenker EH, Zucchi R, Saba A, Colligiani D, Pol CJ, Gerdes AM. Restoration of cardiac tissue thyroid hormone status in experimental hypothyroidism: a dose-response study in female rats. Endocrinology 154: 2542–2552, 2013
20. Weltman NY, Ojamaa K, Schlenker EH, Chen YF, Zucchi R, Saba A, Colligiani D, Rajagopalan V, Pol CJ, Gerdes AM. Low-dose T3 replacement restores depressed cardiac T3 levels, preserves coronary microvasculature, and attenuates cardiac dysfunction in experimental diabetes mellitus. Mol Med 20: 302–312, 2014
21. Young WF Jr, Gorman CA, Jiang NS, Machacek D, Hay ID. L-Thyroxine contamination of pharmaceutical D-thyroxine: probable cause of therapeutic effect. Clin Pharmacol Ther 36: 781–787, 1984
22. Zhang Y, Dedkov EI, Lee B 3rd, Li Y, Pun K, Gerdes AM. Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure model. J Card Fail 20: 1012–1019, 2014
23. Zhang Y, Dedkov EI, Teplitsky D, Weltman NY, Pol CJ, Rajagopalan V, Lee B, Gerdes AM. Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats. Circ Arrhythm Electrophysiol 6: 952–959, 2013.